H uman genetics has a long history of benefiting from technological advances that have made it possible to measure genomic variation. Research over the last 5 years has focused on genome-wide association studies (GWAS), which, for the first time, allow us to measure most of the relevant singlenucleotide polymorphisms (SNPs). 1, 2 Research over the next 5 years will likely focus on measuring the entire genomic sequence in multiple subjects that can be used in application areas like the human microbiome project. 3 Although these technology-driven approaches are thought of as 'genomic' because they measure information from across the genome, they are still primarily approached analytically one SNP at a time. That is, the relationship between interindividual variation in the genome and variation in a given biomedical trait is assessed for each SNP independently of all the other measured SNPs and available measurements of human ecology. There are several reasons for this. First, parametric statistical approaches that form the foundation of statistical genetics and epidemiology are based on the generalized linear model that has much higher power to detect independent main effects than complex interactions among multiple risk factors. As a result, there is a statistical culture of ignoring interactions because interactions are often not detected using methods such as linear regression. Second, there are a number of practical barriers to routine analysis of multiple genetic and environmental risk factors. Powerful machine learning methods and fast parallel computers are needed to detect nonlinear interactions in high-dimensional genomewide datasets. As a result, the special expertize in computer science, software engineering and computer hardware that are needed to implement these methods are often out of reach for the typical geneticist or epidemiologist. Finally, successful detection of nonlinear interactions still requires experimental validation and biological inference, which is much easier if only a single risk factor is considered. The high-throughput experimental methods for perturbing multiple genetic and environmental factors in a model organism or cell line are not yet available.
Now that many of the technical and quality control issues for GWAS have been addressed, it is time to return to thinking about the complex mapping relationship between genotype and phenotype. We desperately need biostatistical and bioinformatics methods that confront and embrace the full complexity of human health and disease. There are signs that the tide is turning. For example, the scientific content of the 2008 meeting of the International Genetic Epidemiology Society had a major emphasis on the use of knowledge about biochemical pathways and gene networks as an integrated part of genetic association analysis including GWAS. This is a recognition that the agnostic statistical paradigm that specifically ignores this type of information will only be useful for uncovering part of the genetic architecture of any given complex trait. In addition to statistical genetics and genetic epidemiology, there is a major paradigm shift happening in bioinformatics. It was evident from the recent 2009 Pacific Symposium on Biocomputing that much more emphasis is being placed on developing algorithms and software for the analysis of systems and networks rather than single biological molecules. As such, the paper by Emily et al 4 showing
how biological networks can be used to guide a GWAS analysis is particularly timely.
It is generally recognized that epistasis or gene -gene interaction plays an important role in the genetic architecture of human health. 5 Detecting and characterizing gene -gene interactions in GWAS is computationally challenging because of the extreme combinatorial nature of the problem. 6 In fact, there are not enough computers in the world to exhaustively enumerate all the three-way, four-way and five-way combinations of SNPs in a GWAS. As such, we need creative alternatives to the brute-force combinatorial approach. One idea is to use our knowledge of protein -protein interactions to help guide a GWAS analysis of epistasis. 7 The idea is that two or more genes with protein products that physically interact are more likely to exhibit a statistical interaction that can be detected in a human population. 
